InvestorsHub Logo
Followers 2
Posts 1360
Boards Moderated 0
Alias Born 01/05/2018

Re: None

Monday, 02/19/2018 10:04:41 AM

Monday, February 19, 2018 10:04:41 AM

Post# of 21540
New video interview with Dr. Alkon:


Some notable things I got out of it:

- The orphan drug status for Fragile X was granted in 2015 by the FDA "within a matter of weeks"

- Dr. Alkon says this designation is "somewhat of an accelerated path to clinical trials"

- Neurotrope is planning a clinical trial for Fragile X "some time in 2018"

- They expect to be working with a collaboration program for this trial

- They have 40 other compounds besides Bryostatin
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News